Frontlight ResearchEarly access
CompletedPhase 1/2
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Key facts
- Who runs it
- Nacuity Pharmaceuticals, Inc.
- Where
- Australia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1/2
- People taking part
- 24 people enrolled
- Started
- 27 Jan 2022
- Ended
- 3 Sept 2026
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- NPI-002 Intravitreal Implant
- Record updated
- 9 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Indicated for vitrectomy
- Natural Lens in place at time of vitrectomy
- Some cataract present as assessed pre-operatively
Who cannot take part
- Previous intraocular surgery in study eye
- Need for oral corticosteroids during study participation
- Not on stable dose of medications for other conditions
- Evidence or history of uveitis, or ocular ischemia
- Evidence or history of proliferative diabetic retinopathy
- Current lung disease (PU, COPD, Asthma) resulting in decreased oxygen saturation
- Clear zonular weakness or defects / coloboma
- Current smoker
- Use of supplemental oxygen
- Sensitivity to thiol compounds
- Participation in another clinical trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
The 3 groups in the trial
- Single NPI-002 Intravitreal ImplantTreatment being tested
one NPI-002 implant inserted at the time of vitrectomy
Treatment: NPI-002 Intravitreal Implant
- Double NPI-002 Intravitreal ImplantTreatment being tested
two NPI-002 implants inserted at the time of vitrectomy
Treatment: NPI-002 Intravitreal Implant
- ControlNo study treatment, for comparison
No implant inserted at time of vitrectomy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
- Record updated
- 9 October 2026